- May 12, 2021
Shifa Launches with Seed Financing to Address Cardiovascular Disease by Developing Orally Bioavailable Drugs for the Treatment of Dyslipidemia
- May 12, 2021
Tellus Therapeutics Secures Seed Financing to Develop the First Treatment for Newborns with White Matter Brain Injury
- May 12, 2021
Peroxitech Therapeutics Secures Seed Financing to Advance New Treatment of Acute Lung Injury
- May 12, 2021
NephroDI Therapeutics Lands Financing to Develop a Treatment for Nephrogenic Diabetes Insipidus, an Orphan Disease
- May 12, 2021
Nephraegis Therapeutics Launches with Seed Financing to Develop Small Molecules to Prevent and Treat Acute Kidney Injury (AKI)
- December 10, 2019